Discover how a groundbreaking cognitive assessment tool is transforming early dementia detection with 99.9% accuracy and what this means for future treatment.

Barlow Center for Memory Evaluation and Treatment, a New York State–funded Center of Excellence for Alzheimer’s Disease, where we care for patients ... Our staff are devoted to research and clinical ...

This test, combined with new blood tests for Alzheimer’s biomarkers ... it could lead to meaningful advances in subtyping, prevention, and treatment.” While much work remains, the research ...

represents an important step toward finding a treatment for frontotemporal dementia. If further research confirms these findings, it could pave the way for new therapies that improve the lives of ...

Warren Foundation then enabled us to partner with DavosPharma to conduct critical early-stage studies and earn approval from the FDA as an investigational new drug, paving the way for the Alzheimer's ...

A new study has demonstrated for the first time how and why music can reduce distress and agitation for people with advanced dementia. There are an estimated 1 million people living with dementia ...

The introduction into clinical practice of disease-modifying treatment for Alzheimer's disease ... of blood-based biomarker diagnostics for Alzheimer disease, in which the key parameters required for ...

Additionally, advances in liquid biopsy methodologies will allow for non-invasive and cost-effective monitoring of tumor dynamics and treatment responses. Neurodegenerative diseases affect over 50 ...

Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to ...

Alzheimer's disease and dementia are the most common neurodegenerative disorder; Since the number of individuals with AD and dementia is expected to increase considerably in the near future reliable ...